Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis
- PMID: 17943286
- DOI: 10.1007/s00281-007-0093-0
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis
Abstract
Anti-neutrophil cytoplasmic autoantibodies (ANCA) and anti-glomerular basement membrane (GBM) necrotizing and crescentic glomerulonephritis are aggressive and destructive glomerular diseases that are associated with and probably caused by circulating ANCA and anti-GBM antibodies. These necrotizing lesions are manifested by acute nephritis and deteriorating kidney function often accompanied by distinctive clinical features of systemic disease. Prompt diagnosis requires clinical acumen that allows for the prompt institution of therapy aimed at removing circulating autoantibodies and quelling the inflammatory process. Continuing exploration of the etiology and pathogenesis of these aggressive inflammatory diseases have gradually uncovered new paradigms for the cause of and more specific therapy for these particular glomerular disorders and for autoimmune glomerular diseases in general.
Similar articles
-
Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.Nephrol Dial Transplant. 2016 Apr;31(4):574-85. doi: 10.1093/ndt/gfv384. Epub 2015 Nov 17. Nephrol Dial Transplant. 2016. PMID: 26582929
-
Effective management of necrotizing crescentic glomerulonephritis using an aggressive combination therapy including avacopan in a patient double-seropositive for anti-GBM antibodies and ANCA: a case report.CEN Case Rep. 2025 Apr;14(2):183-187. doi: 10.1007/s13730-024-00929-4. Epub 2024 Sep 10. CEN Case Rep. 2025. PMID: 39254789 Free PMC article.
-
Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.J Nippon Med Sch. 2015;82(1):27-35. doi: 10.1272/jnms.82.27. J Nippon Med Sch. 2015. PMID: 25797872
-
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.Am J Kidney Dis. 2005 Aug;46(2):253-62. doi: 10.1053/j.ajkd.2005.05.003. Am J Kidney Dis. 2005. PMID: 16112043 Review.
-
Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases.Adv Anat Pathol. 2012 Mar;19(2):111-24. doi: 10.1097/PAP.0b013e318248b7a1. Adv Anat Pathol. 2012. PMID: 22313839 Review.
Cited by
-
Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report.BMC Nephrol. 2020 Jul 17;21(1):283. doi: 10.1186/s12882-020-01947-x. BMC Nephrol. 2020. PMID: 32680573 Free PMC article.
-
Lutheran/basal cell adhesion molecule accelerates progression of crescentic glomerulonephritis in mice.Kidney Int. 2014 May;85(5):1123-36. doi: 10.1038/ki.2013.522. Epub 2014 Jan 15. Kidney Int. 2014. PMID: 24429403 Free PMC article.
-
Crescentic glomerulonephritis with dual positive anti-GBM and C-ANCA/PR3 antibodies.Clin Nephrol Case Stud. 2016 Apr 29;4:5-10. doi: 10.5414/CNCS108666. eCollection 2016. Clin Nephrol Case Stud. 2016. PMID: 29043135 Free PMC article.
-
Advances in human antiglomerular basement membrane disease.Nat Rev Nephrol. 2011 Jul 19;7(12):697-705. doi: 10.1038/nrneph.2011.89. Nat Rev Nephrol. 2011. PMID: 21769105 Review.
-
Pulmonary renal syndrome in a child with coexistence of anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane disease: case report and literature review.BMC Nephrol. 2013 Mar 22;14:66. doi: 10.1186/1471-2369-14-66. BMC Nephrol. 2013. PMID: 23517575 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical